Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 1 Clinical characteristics of study subjects

From: The G-308A variant of the Tumor Necrosis Factor-α (TNF-α) gene is not associated with obesity, insulin resistance and body fat distribution

 

Obese subjects

Lean subjects

p-value

 

(n = 115)

(n = 79)

 

Age (yrs)

47.04 ± 1.3

51.36 ± 1.8

P < 0.01

Sex (M/F)

37 / 78

27/52

NS

BMI (kg/m2)

33.93 ± 0.512

24.30 ± 0.313

<0.0001

Blood glucose (mg/dl)

91.56 ± 2.0

86.84 ± 10.08

NS

Fasting plasma insulin (μU/ml)

22.72 ± 1.7

9.29 ± 1.04

<0.0001

HOMAIR

5 ± 0.16

2.2 ± 0.45

<0.0003

Plasma lipids (mg/dL)

   

   Total cholesterol

218.69 ± 4.5

214.95 ± 6.1

NS

   HDL cholesterol.

48.16 ± 1.4

48.2 ± 2.2

NS

   Total triglycerides

156.85 ± 12.5

157.26 ± 12.96

NS

   LDL cholesterol

128.61 ± 5.1

131.2 ± 5

NS

  1. Data are given as means ± SEM. All p-values were corrected for differences in age The statistical analysis of total triglycerides and plasma insulin were performed on log-trasformed values, but the untrasformed values are given in table. Continuous variables were compared by t-test and categorical variables by Χ2 test.